Leveraging our understanding of the mechanisms of cancer-mediated cGAS–STING pathway control and how cGAS–STING signalling can be beneficial to the tumour could identify novel therapeutic targets in chromosomally unstable cancer. The gene discussed is CGAS; the disease is cancer.